Comments for QGEN - Stockpickr! Your Source for Stock Ideas

Comments for QGEN

Added By	Comments	Type	Date Added
High Dividends	5.3	Love	November 19, 2008
barrons2	Outperform/Higher Risk - Price 20.26 on July 1 by Baird Securities QGEN announced it has acquired Corbett Life Science in a cash and stock deal worth $70 million plus $65 million in future milestones....We have adjusted our 2008-'09 estimates to reflect anticipated acquisition impact. Our 28 target is based on a target P/E multiple of 30 times [in line with a historical range of 25 times to 45 times for molecular-diagnostics companies] and our '09 pro forma E-EPS of 94 cents. We believe QGEN should trade at a higher P/E multiple relative to its life-science peers, based on Qiagen's sustained double-digit organic growth rate and 20% to 30% operating margins. Market cap: $3.6 billion.	Love	July 05, 2008
gross641	Great business model, and growth opportunities with their recent acquisition of Digene.	Love	January 13, 2008
smcwilli	unknown	Hate	October 15, 2007
duckswin	bio testing	Love	July 17, 2007
pickr007	DNA test for flu viruses	Love	May 08, 2007
sarah z	DNA test for flu viruses	Love	May 03, 2007
flametrower49	biotech	Love	April 14, 2007
gross641	45% Growth rate in Asia. This is a safe way to enter biotech. Set to exceed 2007 sales forecast according to the conference call.	Love	February 25, 2007
cy goo	bio weapons defense, possible contract...	Love	January 10, 2007